GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) » Definitions » EBIT

Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) EBIT : €0.61 Mil (TTM As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Laboratorio Farmaceutico Erfo SpA EBIT?

Laboratorio Farmaceutico Erfo SpA's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2024 was €0.43 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2024 was €0.61 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Laboratorio Farmaceutico Erfo SpA's annualized ROC % for the quarter that ended in Jun. 2024 was 7.48%. Laboratorio Farmaceutico Erfo SpA's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 32.81%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Laboratorio Farmaceutico Erfo SpA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 6.47%.


Laboratorio Farmaceutico Erfo SpA EBIT Historical Data

The historical data trend for Laboratorio Farmaceutico Erfo SpA's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorio Farmaceutico Erfo SpA EBIT Chart

Laboratorio Farmaceutico Erfo SpA Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
1.83 1.49 1.57 0.99 0.85

Laboratorio Farmaceutico Erfo SpA Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EBIT Get a 7-Day Free Trial Premium Member Only 0.68 0.31 0.66 0.18 0.43

Competitive Comparison of Laboratorio Farmaceutico Erfo SpA's EBIT

For the Packaged Foods subindustry, Laboratorio Farmaceutico Erfo SpA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laboratorio Farmaceutico Erfo SpA's EV-to-EBIT Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Laboratorio Farmaceutico Erfo SpA's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Laboratorio Farmaceutico Erfo SpA's EV-to-EBIT falls into.



Laboratorio Farmaceutico Erfo SpA EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.61 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Laboratorio Farmaceutico Erfo SpA  (MIL:ERFO) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Laboratorio Farmaceutico Erfo SpA's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

ROC % (Q: Jun. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Jun. 2024 ))/ count )
=0.898 * ( 1 - 30.24% )/( (8.638 + 8.105)/ 2 )
=0.6264448/8.3715
=7.48 %

where

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Laboratorio Farmaceutico Erfo SpA's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Jun. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=0.85/( ( (2.15 + max(0.996, 0)) + (2.035 + max(-0.301, 0)) )/ 2 )
=0.85/( ( 3.146 + 2.035 )/ 2 )
=0.85/2.5905
=32.81 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.665 + 0.996 + 0) - (0.665 + 0 + 1.1102230246252E-16)
=0.996

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.554 + 1.126 + 0.349) - (0.898 + 0 + 1.432)
=-0.301

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Laboratorio Farmaceutico Erfo SpA's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2024 )
=0.606/9.373
=6.47 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Laboratorio Farmaceutico Erfo SpA EBIT Related Terms

Thank you for viewing the detailed overview of Laboratorio Farmaceutico Erfo SpA's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Laboratorio Farmaceutico Erfo SpA Business Description

Traded in Other Exchanges
Address
Viale Geki Russo Lo. Pontegallo, Villafranca Tirrena, Messina, ITA, 98049
Laboratorio Farmaceutico Erfo SpA operates in the nutraceutical sector. The company specializes in formulating and producing food supplements and natural medicines in different forms such as liquids, powders, granules, tablets, and soft gels. Geographically, the company generates a majority of its revenue from Italy followed by Spain, France, Belgium, and other countries.

Laboratorio Farmaceutico Erfo SpA Headlines

No Headlines